**Patient Discharge Summary**

**Patient Information:**  
- Name: [Patient Name]  
- ID: [Patient ID]  
- Date of Birth: [DOB]  
- Admission Date: [Admission Date]  
- Discharge Date: [Discharge Date]  
- Attending Physician: Dr. [Physician Name]  
- Department: Infectious Diseases Unit  

**Chief Complaint:**  
The patient presented to the emergency department on [Admission Date] with symptoms suggestive of influenza, including high fever, severe muscle aches, cough, and sore throat. The patient reported symptoms onset approximately 2 days prior to admission.

**History of Present Illness:**  
[Patient Name], a [Age]-year-old [male/female] with no significant past medical history, began experiencing symptoms of influenza, including fever, cough, and malaise, approximately 2 days before admission. The symptoms progressively worsened, prompting the visit to the emergency department. The patient denied any recent travel history or known exposure to individuals with similar symptoms.

**Physical Examination:**  
Upon admission, the patient was febrile with a temperature of 38.5°C (101.3°F), heart rate of 102 bpm, respiratory rate of 20 breaths per minute, and blood pressure of 120/80 mmHg. Examination revealed bilateral rhonchi on chest auscultation, and the patient appeared fatigued but was oriented and coherent.

**Diagnostic Tests and Results:**  
- Rapid antigen test for influenza: Positive for influenza A.
- RT-PCR test confirmed the presence of influenza A subtype H3N2.
- Chest x-ray performed on [Date of Chest X-Ray], showed no signs of pneumonia.
- Pulse oximetry showed an oxygen saturation of 96% on room air.

**Hospital Course:**  
The patient was admitted to the Infectious Diseases Unit under isolation precautions due to confirmed influenza A infection. Symptomatic treatment was initiated, including hydration and antipyretics (acetaminophen). Given the patient’s severe symptoms and within 48 hours of symptom onset, antiviral therapy with Oseltamivir 75 mg orally twice a day was started on [Date of Antiviral Therapy Start] and continued for a total of 5 days.

The patient's fever resolved on [Date of Fever Resolution], and significant improvement in respiratory symptoms was noted by [Date of Symptom Improvement]. The patient remained hemodynamically stable throughout the hospital stay, with no evidence of secondary bacterial infection.

**Medications at Discharge:**  
- Oseltamivir 75 mg orally twice a day, completed on [Date of Antiviral Therapy Completion].
- Acetaminophen 650 mg orally every 6 hours as needed for fever or pain.

**Follow-Up:**  
The patient is advised to follow up with their primary care physician in 7 days or sooner if symptoms recur or worsen. The patient has been counseled on the importance of rest, hydration, and infection control practices, including staying isolated until 24 hours after fever resolution without the use of fever-reducing medications.

**Discharge Instructions:**  
- Continue to rest and maintain adequate hydration.
- Avoid contact with other individuals until fully recovered, especially those who are very young, elderly, or have compromised immune systems.
- Wash hands frequently with soap and water or use an alcohol-based hand sanitizer.
- Cover mouth and nose with a tissue or sleeve when coughing or sneezing.

**Precautions:**  
The patient has been advised to seek immediate medical attention if they experience difficulty breathing, chest pain, persistent high fever, or signs of secondary infection.

**Summary:**  
[Patient Name] was admitted with a diagnosis of influenza A and has shown significant improvement with antiviral therapy and symptomatic treatment. The patient is being discharged in a stable condition with instructions for follow-up and self-care at home. 

---

**Note:** The above discharge summary is a simulated document for a hypothetical patient based on the provided guidelines and should be adapted to specific patient details and hospital protocols.